Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: Analysis of a cohort of 214 patients.

Paule R, Morel N, Le Guern V, Fredi M, Coutte L, Belhocine M, Mouthon L, le Jeunne C, Chauvin A, Piette JC, Costedoat-Chalumeau N.

Autoimmun Rev. 2018 Jul 10. pii: S1568-9972(18)30156-3. doi: 10.1016/j.autrev.2018.03.011. [Epub ahead of print] Review.

PMID:
30005859
2.

Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.

Fredi M, Andreoli L, Aggogeri E, Bettiga E, Lazzaroni MG, Le Guern V, Lojacono A, Morel N, Piette JC, Zatti S, Costedoat-Chalumeau N, Tincani A.

Front Immunol. 2018 May 7;9:864. doi: 10.3389/fimmu.2018.00864. eCollection 2018.

3.

Disease severity of proliferative lupus nephritis in Maghrebians.

Tamirou F, Costedoat-Chalumeau N, Medkouri G, Daugas E, Hachulla E, Jourde-Chiche N, Karras A, le Guern V, Gnemmi V, Jadoul M, Houssiau FA.

Lupus. 2018 Jul;27(8):1387-1392. doi: 10.1177/0961203318772016. Epub 2018 Apr 27.

PMID:
29703123
4.

[Chronic histiocytic intervillositis: Diagnosis and management].

Mekinian A, Costedoat-Chalumeau N, Carbillon L, Coulomb-L'Hermine A, Le Guern V, Masseau A, Lazaro E, Cohen J, Bornes M, Kayem G, Fain O.

Rev Med Interne. 2018 Feb;39(2):117-121. doi: 10.1016/j.revmed.2017.10.422. Epub 2017 Nov 13. French.

PMID:
29146013
5.

[Indirect causes of maternal deaths (except stroke, cardiovascular diseases and infections): Results from the French confidential enquiry into maternal deaths, 2010-2012].

Le Guern V, Rossignol M, Proust A.

Gynecol Obstet Fertil Senol. 2017 Dec;45(12S):S71-S80. doi: 10.1016/j.gofs.2017.10.018. Epub 2017 Nov 4. French.

PMID:
29113876
6.

A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.

Costedoat-Chalumeau N, Houssiau F, Izmirly P, Le Guern V, Navarra S, Jolly M, Ruiz-Irastorza G, Baron G, Hachulla E, Agmon-Levin N, Shoenfeld Y, Dall'Ara F, Buyon J, Deligny C, Cervera R, Lazaro E, Bezanahary H, Leroux G, Morel N, Viallard JF, Pineau C, Galicier L, Van Vollenhoven R, Tincani A, Nguyen H, Gondran G, Zahr N, Pouchot J, Piette JC, Petri M, Isenberg D.

Clin Pharmacol Ther. 2018 Jun;103(6):1074-1082. doi: 10.1002/cpt.885. Epub 2017 Nov 9.

PMID:
28925027
7.

Role of the IL-12/IL-35 balance in patients with Sjögren syndrome.

Fogel O, Rivière E, Seror R, Nocturne G, Boudaoud S, Ly B, Gottenberg JE, Le Guern V, Dubost JJ, Nititham J, Taylor KE, Chanson P, Dieudé P, Criswell LA, Jagla B, Thai A, Mingueneau M, Mariette X, Miceli-Richard C.

J Allergy Clin Immunol. 2018 Jul;142(1):258-268.e5. doi: 10.1016/j.jaci.2017.07.041. Epub 2017 Sep 12.

PMID:
28916184
8.

Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry.

Hachulla E, Jais X, Cinquetti G, Clerson P, Rottat L, Launay D, Cottin V, Habib G, Prevot G, Chabanne C, Foïs E, Amoura Z, Mouthon L, Le Guern V, Montani D, Simonneau G, Humbert M, Sobanski V, Sitbon O; French Collaborators Recruiting Members(∗).

Chest. 2018 Jan;153(1):143-151. doi: 10.1016/j.chest.2017.08.014. Epub 2017 Aug 26.

PMID:
28851621
9.

Pneumococcal vaccination in patients with systemic lupus erythematosus: A multicenter placebo-controlled randomized double-blind study.

Grabar S, Groh M, Bahuaud M, Le Guern V, Costedoat-Chalumeau N, Mathian A, Hanslik T, Guillevin L, Batteux F, Launay O; VACCILUP study group.

Vaccine. 2017 Sep 5;35(37):4877-4885. doi: 10.1016/j.vaccine.2017.07.094. Epub 2017 Aug 4.

PMID:
28784280
10.

Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective study.

Chavarot N, Verhelst D, Pardon A, Caudwell V, Mercadal L, Sacchi A, Leonardi C, Le Guern V, Karras A, Daugas E; Groupe Coopératif sur le Lupus Rénal.

Medicine (Baltimore). 2017 Jul;96(27):e7429. doi: 10.1097/MD.0000000000007429.

11.

Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.

Puéchal X, Pagnoux C, Baron G, Quémeneur T, Néel A, Agard C, Lifermann F, Liozon E, Ruivard M, Godmer P, Limal N, Mékinian A, Papo T, Ruppert AM, Bourgarit A, Bienvenu B, Geffray L, Saraux JL, Diot E, Crestani B, Delbrel X, Sailler L, Cohen P, Le Guern V, Terrier B, Groh M, Le Jeunne C, Mouthon L, Ravaud P, Guillevin L; French Vasculitis Study Group.

Arthritis Rheumatol. 2017 Nov;69(11):2175-2186. doi: 10.1002/art.40205. Epub 2017 Oct 15.

PMID:
28678392
12.

Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients.

Gavand PE, Serio I, Arnaud L, Costedoat-Chalumeau N, Carvelli J, Dossier A, Hinschberger O, Mouthon L, Le Guern V, Korganow AS, Poindron V, Gourguechon C, Lavigne C, Maurier F, Labro G, Heymonet M, Artifoni M, Viau AB, Deligny C, Sene T, Terriou L, Sibilia J, Mathian A, Bloch-Queyrat C, Larroche C, Amoura Z, Martin T.

Autoimmun Rev. 2017 Jul;16(7):743-749. doi: 10.1016/j.autrev.2017.05.010. Epub 2017 May 5. Review.

PMID:
28483541
13.

International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus.

Kleinmann JF, Tubach F, Le Guern V, Mathian A, Richez C, Saadoun D, Sacre K, Sellam J, Seror R, Amoura Z, Andres E, Audia S, Bader-Meunier B, Blaison G, Bonnotte B, Cacoub P, Caillard S, Chiche L, Chosidow O, Costedoat-Chalumeau N, Daien C, Daugas E, Derdèche N, Doria A, Fain O, Fakhouri F, Farge D, Gabay C, Guillo S, Hachulla E, Hajjaj-Hassouni N, Hamidou M, Houssiau FA, Jourde-Chiche N, Koné-Paut I, Ladjouz-Rezig A, Lambotte O, Lipsker D, Mariette X, Martin-Silva N, Martin T, Maurier F, Meckenstock R, Mékinian A, Meyer O, Mohamed S, Morel J, Moulin B, Mulleman D, Papo T, Poindron V, Puéchal X, Punzi L, Quartier P, Sailler L, Smail A, Soubrier M, Sparsa A, Tazi-Mezalek Z, Zakraoui L, Zuily S, Sibilia J, Gottenberg JE.

Autoimmun Rev. 2017 Jun;16(6):650-657. doi: 10.1016/j.autrev.2017.04.011. Epub 2017 Apr 18.

PMID:
28434948
14.

In Vitro Fertilization in 37 Women with Systemic Lupus Erythematosus or Antiphospholipid Syndrome: A Series of 97 Procedures.

Orquevaux P, Masseau A, Le Guern V, Gayet V, Vauthier D, Guettrot-Imbert G, Huong DLT, Wechsler B, Morel N, Cacoub P, Pennaforte JL, Piette JC, Costedoat-Chalumeau N.

J Rheumatol. 2017 May;44(5):613-618. doi: 10.3899/jrheum.160462. Epub 2017 Jan 15.

PMID:
28089975
15.

A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren's syndrome.

Jasiek M, Karras A, Le Guern V, Krastinova E, Mesbah R, Faguer S, Jourde-Chiche N, Fauchais AL, Chiche L, Dernis E, Moulis G, Fraison JB, Lazaro E, Jullien P, Hachulla E, Le Quellec A, Rémy P, Hummel A, Costedoat-Chalumeau N, Ronco P, Vanhille P, Meas-Yedid V, Cordonnier C, Ferlicot S, Daniel L, Seror R, Mariette X, Thervet E, François H, Terrier B.

Rheumatology (Oxford). 2017 Mar 1;56(3):362-370. doi: 10.1093/rheumatology/kew376.

16.

A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS).

van Vollenhoven R, Voskuyl A, Bertsias G, Aranow C, Aringer M, Arnaud L, Askanase A, Balážová P, Bonfa E, Bootsma H, Boumpas D, Bruce I, Cervera R, Clarke A, Coney C, Costedoat-Chalumeau N, Czirják L, Derksen R, Doria A, Dörner T, Fischer-Betz R, Fritsch-Stork R, Gordon C, Graninger W, Györi N, Houssiau F, Isenberg D, Jacobsen S, Jayne D, Kuhn A, Le Guern V, Lerstrøm K, Levy R, Machado-Ribeiro F, Mariette X, Missaykeh J, Morand E, Mosca M, Inanc M, Navarra S, Neumann I, Olesinska M, Petri M, Rahman A, Rekvig OP, Rovensky J, Shoenfeld Y, Smolen J, Tincani A, Urowitz M, van Leeuw B, Vasconcelos C, Voss A, Werth VP, Zakharova H, Zoma A, Schneider M, Ward M.

Ann Rheum Dis. 2017 Mar;76(3):554-561. doi: 10.1136/annrheumdis-2016-209519. Epub 2016 Nov 24. Review.

PMID:
27884822
17.

[Blood concentration of hydroxychloroquine in systemic lupus erythematosus care: Usefulness and limits].

Costedoat-Chalumeau N, Tamirou F, Le Guern V, Blanchet B, Deligny C, Piette JC.

Rev Med Interne. 2017 Feb;38(2):77-80. doi: 10.1016/j.revmed.2016.07.001. Epub 2016 Oct 13. French. No abstract available.

PMID:
27745934
18.

[2016 review on catastrophic antiphospholipid syndrome].

Costedoat-Chalumeau N, Coutte L, Le Guern V, Morel N, Leroux G, Paule R, Mouthon L, Piette JC.

Presse Med. 2016 Dec;45(12 Pt 1):1084-1092. doi: 10.1016/j.lpm.2016.07.023. Epub 2016 Sep 9. Review. French.

PMID:
27617783
19.

Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial.

Cornec D, Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puéchal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Yves Hatron P, Goeb V, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Saliou P, Pers JO, Seror R, Saraux A.

Arthritis Care Res (Hoboken). 2017 Apr;69(4):528-535. doi: 10.1002/acr.22974.

20.

Pneumococcal and influenza vaccination rates in patients treated with corticosteroids and/or immunosuppressive therapies for systemic autoimmune diseases: A cross-sectional study.

Assala M, Groh M, Blanche P, Vinter C, Cohen P, Le Guern V, Puéchal X, Mouthon L, Le Jeunne C, Launay O, Kernéis S.

Joint Bone Spine. 2017 May;84(3):365-366. doi: 10.1016/j.jbspin.2016.03.013. Epub 2016 Jun 22. No abstract available.

PMID:
27344076
21.

A glittering spleen.

Durel CA, Groh M, Le Guern V.

Joint Bone Spine. 2017 May;84(3):363. doi: 10.1016/j.jbspin.2016.04.009. Epub 2016 Jun 17. No abstract available.

PMID:
27324604
22.

Pregnancy and contraception in systemic and cutaneous lupus erythematosus.

Guettrot-Imbert G, Morel N, Le Guern V, Plu-Bureau G, Frances C, Costedoat-Chalumeau N.

Ann Dermatol Venereol. 2016 Oct;143(10):590-600. doi: 10.1016/j.annder.2015.07.015. Epub 2016 Apr 26. Review.

PMID:
27129743
23.

Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort.

Carvajal Alegria G, Guellec D, Mariette X, Gottenberg JE, Dernis E, Dubost JJ, Trouvin AP, Hachulla E, Larroche C, Le Guern V, Cornec D, Devauchelle-Pensec V, Saraux A.

RMD Open. 2016 Apr 20;2(1):e000179. doi: 10.1136/rmdopen-2015-000179. eCollection 2016.

24.

Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide.

Audemard-Verger A, Martin Silva N, Verstuyft C, Costedoat-Chalumeau N, Hummel A, Le Guern V, Sacré K, Meyer O, Daugas E, Goujard C, Sultan A, Lobbedez T, Galicier L, Pourrat J, Le Hello C, Godin M, Morello R, Lambert M, Hachulla E, Vanhille P, Queffeulou G, Potier J, Dion JJ, Bataille P, Chauveau D, Moulis G, Farge-Bancel D, Duhaut P, Saint-Marcoux B, Deroux A, Manuzak J, Francès C, Aumaitre O, Bezanahary H, Becquemont L, Bienvenu B.

PLoS One. 2016 Mar 22;11(3):e0151696. doi: 10.1371/journal.pone.0151696. eCollection 2016.

25.

[Prevention of infections in adults and adolescents with systemic lupus erythematosus: Guidelines for the clinical practice based on the literature and expert opinion].

Mathian A, Arnaud L, Adoue D, Agard C, Bader-Meunier B, Baudouin V, Belizna C, Bonnotte B, Boumedine F, Chaib A, Chauchard M, Chiche L, Daugas E, Ghali A, Gobert P, Gondran G, Guettrot-Imbert G, Hachulla E, Hamidou M, Haroche J, Hervier B, Hummel A, Jourde-Chiche N, Korganow AS, Kwon T, Le Guern V, Le Quellec A, Limal N, Magy-Bertrand N, Marianetti-Guingel P, Martin T, Martin Silva N, Meyer O, Miyara M, Morell-Dubois S, Ninet J, Pennaforte JL, Polomat K, Pourrat J, Queyrel V, Raymond I, Remy P, Sacre K, Sibilia J, Viallard JF, Viau Brabant A, Hanslik T, Amoura Z; le groupe France lupus érythémateux systémique réseau (FLEUR) et les centres de référence et de compétence des lupus et syndromes des antiphospholipides.

Rev Med Interne. 2016 May;37(5):307-20. doi: 10.1016/j.revmed.2016.01.005. Epub 2016 Feb 16. French.

PMID:
26899776
26.

Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levels.

Jolly M, Galicier L, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Boutin DL, Asli B, Kahn JE, Pourrat J, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Jallouli M, Leroux G, Cohen-Bittan J, Hulot JS, Arora S, Amoura Z, Piette JC, Costedoat-Chalumeau N; PLUS group.

Lupus. 2016 Jun;25(7):735-40. doi: 10.1177/0961203315627200. Epub 2016 Feb 13.

PMID:
26876692
27.

Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome.

Nocturne G, Virone A, Ng WF, Le Guern V, Hachulla E, Cornec D, Daien C, Vittecoq O, Bienvenu B, Marcelli C, Wendling D, Amoura Z, Dhote R, Lavigne C, Fior R, Gottenberg JE, Seror R, Mariette X.

Arthritis Rheumatol. 2016 Apr;68(4):977-85. doi: 10.1002/art.39518.

28.

Routine Hydroxychloroquine Blood Concentration Measurement in Systemic Lupus Erythematosus Reaches Adulthood.

Costedoat-Chalumeau N, LE Guern V, Piette JC.

J Rheumatol. 2015 Nov;42(11):1997-9. doi: 10.3899/jrheum.151094. No abstract available.

PMID:
26523036
29.

Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?

Devauchelle-Pensec V, Gottenberg JE, Jousse-Joulin S, Berthelot JM, Perdriger A, Hachulla E, Hatron PY, Puechal X, Le Guern V, Sibilia J, Chiche L, Goeb V, Vittecoq O, Larroche C, Fauchais AL, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Dieudé P, Pers JO, Cornec D, Seror R, Mariette X, Nowak E, Saraux A.

PLoS One. 2015 Sep 14;10(9):e0133907. doi: 10.1371/journal.pone.0133907. eCollection 2015.

30.

CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome.

Nocturne G, Seror R, Fogel O, Belkhir R, Boudaoud S, Saraux A, Larroche C, Le Guern V, Gottenberg JE, Mariette X.

Arthritis Rheumatol. 2015 Dec;67(12):3226-33. doi: 10.1002/art.39315.

31.

Colchicine: a simple and effective treatment for pericarditis in systemic lupus erythematosus? A report of 10 cases.

Morel N, Bonjour M, Le Guern V, Le Jeunne C, Mouthon L, Piette JC, Costedoat-Chalumeau N.

Lupus. 2015 Dec;24(14):1479-85. doi: 10.1177/0961203315593169. Epub 2015 Jul 10.

PMID:
26163661
32.

Granulomatosis with polyangiitis: endoscopic management of tracheobronchial stenosis: results from a multicentre experience.

Terrier B, Dechartres A, Girard C, Jouneau S, Kahn JE, Dhote R, Lazaro E, Cabane J, Papo T, Schleinitz N, Cohen P, Begon E, Belenotti P, Chauveau D, Diot E, Généreau T, Hamidou M, Hayem G, Le Guenno G, Le Guern V, Michel M, Moulis G, Puéchal X, Rivière S, Samson M, Gonin F, Le Jeunne C, Corlieu P, Mouthon L, Guillevin L; French Vasculitis Study Group.

Rheumatology (Oxford). 2015 Oct;54(10):1852-7. doi: 10.1093/rheumatology/kev129. Epub 2015 May 21.

PMID:
26001634
33.

Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.

Jallouli M, Galicier L, Zahr N, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Le Thi Huong D, Asli B, Kahn JE, Pourrat J, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Leroux G, Cohen-Bittan J, Sellam J, Mariette X, Blanchet B, Hulot JS, Amoura Z, Piette JC, Costedoat-Chalumeau N; Plaquenil Lupus Systemic Study Group.

Arthritis Rheumatol. 2015 May;67(8):2176-84. doi: 10.1002/art.39194.

34.

Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.

Cornec D, Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puéchal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Hatron PY, Goeb V, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Seror R, Pers JO, Meiners PM, Vissink A, Bootsma H, Nowak E, Saraux A.

Rheumatology (Oxford). 2015 Sep;54(9):1699-708. doi: 10.1093/rheumatology/kev114. Epub 2015 May 8.

PMID:
25957440
35.

Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis.

Tamirou F, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Fiehn C, Ayala Guttierez Mdel M, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R, Houssiau FA; MAINTAIN Nephritis Trial Group.

Ann Rheum Dis. 2016 Mar;75(3):526-31. doi: 10.1136/annrheumdis-2014-206897. Epub 2015 Mar 10.

36.

Sjögren's syndrome complicated by interstitial cystitis: A case series and literature review.

Darrieutort-Laffite C, André V, Hayem G, Saraux A, Le Guern V, Le Jeunne C, Puéchal X.

Joint Bone Spine. 2015 Jul;82(4):245-50. doi: 10.1016/j.jbspin.2014.12.007. Epub 2015 Feb 10. Review.

PMID:
25680227
37.

A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye.

Costedoat-Chalumeau N, Dunogué B, Leroux G, Morel N, Jallouli M, Le Guern V, Piette JC, Brézin AP, Melles RB, Marmor MF.

Clin Rev Allergy Immunol. 2015 Dec;49(3):317-26. doi: 10.1007/s12016-015-8469-8. Review.

PMID:
25672591
38.

[Liver diseases and pregnancy].

Guettrot-Imbert G, Plessier A, Hillaire S, Delluc C, Leroux G, Le Guern V, Costedoat-Chalumeau N.

Rev Med Interne. 2015 Mar;36(3):211-8. doi: 10.1016/j.revmed.2014.10.355. Epub 2015 Jan 12. Review. French.

PMID:
25591870
39.

[Systemic lupus erythematosus and antiphospholipid syndrome: How to manage pregnancy?].

Guettrot-Imbert G, Le Guern V, Morel N, Vauthier D, Tsatsaris V, Pannier E, Piette JC, Costedoat-Chalumeau N.

Rev Med Interne. 2015 Mar;36(3):173-81. doi: 10.1016/j.revmed.2014.12.005. Epub 2015 Jan 8. French.

40.

[The pre-pregnancy counseling].

Le Guern V, Guettrot-Imbert G, Costedoat-Chalumeau N.

Rev Med Interne. 2015 Mar;36(3):151-3. doi: 10.1016/j.revmed.2014.07.012. Epub 2014 Dec 22. French.

PMID:
25541231
41.

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).

Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG, Baron G, Le Guern V, Devauchelle-Pensec V, Ramos-Casals M, Valim V, Dörner T, Tzioufas A, Gottenberg JE, Solans Laqué R, Mandl T, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Priori R, Bartoloni E, Goeb V, Praprotnik S, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Meiners P, Brito-Zerón P, Vitali C, Mariette X; EULAR Sjögren's Task Force.

Ann Rheum Dis. 2016 Feb;75(2):382-9. doi: 10.1136/annrheumdis-2014-206008. Epub 2014 Dec 5.

PMID:
25480887
42.

[Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion].

Arnaud L, Mathian A, Adoue D, Bader-Meunier B, Baudouin V, Belizna C, Bonnotte B, Boumedine F, Chaib A, Chauchard M, Chiche L, Daugas E, Ghali A, Gobert P, Gondran G, Guettrot-Imbert G, Hachulla E, Hamidou M, Haroche J, Hervier B, Hummel A, Jourde-Chiche N, Korganow AS, Kwon T, Le Guern V, Le Quellec A, Limal N, Magy-Bertrand N, Marianetti-Guingel P, Martin T, Martin Silva N, Meyer O, Miyara M, Morell-Dubois S, Ninet J, Papo T, Pennaforte JL, Polomat K, Pourrat J, Queyrel V, Raymond I, Remy P, Sacre K, Schmidt J, Sibilia J, Viallard JF, Viau Brabant A, Wahl D, Bruckert E, Amoura Z; groupe France Lupus Érythémateux systémique Réseau (FLEUR) et les centres de référence et de compétence des lupus et syndromes des antiphospholipides.

Rev Med Interne. 2015 Jun;36(6):372-80. doi: 10.1016/j.revmed.2014.10.009. Epub 2014 Nov 14. French.

PMID:
25455954
43.

Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up.

Schoindre Y, Jallouli M, Tanguy ML, Ghillani P, Galicier L, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Le Thi Huong D, Asli B, Kahn JE, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Leroux G, Cohen-Bittan J, Hulot JS, Lechat P, Musset L, Piette JC, Amoura Z, Souberbielle JC, Costedoat-Chalumeau N; Group PLUS.

Lupus Sci Med. 2014 Jun 7;1(1):e000027. doi: 10.1136/lupus-2014-000027. eCollection 2014.

44.

[Neonatal lupus syndrome: Literature review].

Morel N, Georgin-Lavialle S, Levesque K, Guettrot-Imbert G, Le Guern V, Le Bidois J, Bessières B, Brouzes C, Le Mercier D, Villain E, Maltret A, Costedoat-Chalumeau N.

Rev Med Interne. 2015 Mar;36(3):159-66. doi: 10.1016/j.revmed.2014.07.013. Epub 2014 Sep 17. Review. French.

PMID:
25240481
45.

[In vitro fertilization and systemic lupus erythematosus or antiphospholipid syndrome: An update].

Orquevaux P, Masseau A, Le Guern V, Gayet V, Vauthier D, Boutin D, Wechsler B, Morel N, Guettrot-Imbert G, Pennaforte JL, Piette JC, Costedoat-Chalumeau N.

Rev Med Interne. 2015 Mar;36(3):154-8. doi: 10.1016/j.revmed.2014.08.004. Epub 2014 Sep 10. Review. French.

PMID:
25217451
46.

Obstetrical APS: is there a place for hydroxychloroquine to improve the pregnancy outcome?

Mekinian A, Costedoat-Chalumeau N, Masseau A, Tincani A, De Caroli S, Alijotas-Reig J, Ruffatti A, Ambrozic A, Botta A, Le Guern V, Fritsch-Stork R, Nicaise-Roland P, Carbonne B, Carbillon L, Fain O.

Autoimmun Rev. 2015 Jan;14(1):23-9. doi: 10.1016/j.autrev.2014.08.040. Epub 2014 Aug 30. Review.

PMID:
25179813
47.

Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial.

Gottenberg JE, Ravaud P, Puéchal X, Le Guern V, Sibilia J, Goeb V, Larroche C, Dubost JJ, Rist S, Saraux A, Devauchelle-Pensec V, Morel J, Hayem G, Hatron P, Perdriger A, Sene D, Zarnitsky C, Batouche D, Furlan V, Benessiano J, Perrodeau E, Seror R, Mariette X.

JAMA. 2014 Jul 16;312(3):249-58. doi: 10.1001/jama.2014.7682.

PMID:
25027140
48.

Hydroxychloroquine: a multifaceted treatment in lupus.

Costedoat-Chalumeau N, Dunogué B, Morel N, Le Guern V, Guettrot-Imbert G.

Presse Med. 2014 Jun;43(6 Pt 2):e167-80. doi: 10.1016/j.lpm.2014.03.007. Epub 2014 May 19. Review.

PMID:
24855048
49.

Error in the Abstract in the Article by Maldini et al (Arthritis Care Res [Hoboken], March 2014).

Maldini C, Seror R, Fain O, Dhote R, Amoura Z, De Bandt M, Delassus JL, Falgarone G, Guillevin L, Le Guern V, Lhote F, Meyer O, Ramanoelina J, Sacré K, Uzunhan Y, Leroux JL, Mariette X, Mahr A.

Arthritis Care Res (Hoboken). 2014 May;66(5):794. doi: 10.1002/acr.22347. No abstract available.

50.

Treatment of primary Sjögren syndrome with rituximab: a randomized trial.

Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puéchal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Hatron PY, Goeb V, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Pers JO, Nowak E, Saraux A.

Ann Intern Med. 2014 Feb 18;160(4):233-42.

PMID:
24727841

Supplemental Content

Loading ...
Support Center